Company: INMB
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003354
Chunk: 473

Company: Inmune Bio, Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 2
Chunk 473
---
 2025
    Raymond J. Tesi, M.D.

    Chief Executive Officer 

    (Principal Executive Officer)

    /s/ David J. Moss
  
    Dated: March 27, 2025
    David J. Moss

    Chief Financial Officer

    (Principal Financial and Accounting Officer)

Pursuant to the requirements of the Securities
Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and
on the dates indicated.

    Signature
     
    Title
     
    Date

    /s/ Raymond J. Tesi

    Raymond J. Tesi, M.D.
     
    President, Chief Executive Officer and Director
(Principal Executive Officer)
     
    March 27, 2025

    /s/ David J. Moss

    David J. Moss
     
    Chief Financial Officer, Treasurer, Secretary
(Principal Financial and Accounting Officer)
     
    March 27, 2025

    /s/ Timothy Schroeder

    Timothy Schroeder
     
    Director
     
    March 27, 2025

    /s/ J. Kelly Ganjei

    J. Kelly Ganjei
     
    Director
     
    March 27, 2025 

    /s/ Scott Juda, JD

    Scott Juda, JD
     
    Director
     
    March 27, 2025

    /s/ Marcia Allen

    Marcia Allen
     
    Director
     
    March 27, 2025

73

0001711754
false
FY

    0001711754

    2024-01-01
    2024-12-31

    0001711754

    2024-06-30

    0001711754

    2025-03-27

    0001711754

    2024-12-31

    0001711754

    2023-12-31

    0001711754
    
      us-gaap:RelatedPartyMember

    2024-12-31

    0001711754
    
      us-gaap:RelatedPartyMember

    2023-12-31

    0001711754

    2023-01-01
    2023-12-